The provided source material pertains exclusively to the professional profile of Dr. Matthew Freeby, an endocrinologist based in the United States. The documents detail his academic background, clinical roles, research publications, and professional affiliations. There is no information within the source data regarding free samples, promotional offers, no-cost product trials, brand freebies, or mail-in sample programmes in the UK or any other market. Consequently, it is not possible to generate a detailed article on the requested topic using the provided materials.
The following is a factual summary based solely on the available data.
Professional Profile Summary
Dr. Matthew Freeby is an Assistant Clinical Professor of Medicine at the David Geffen UCLA School of Medicine. He holds the positions of Director of the Gonda Diabetes Center and Associate Director of Diabetes Clinical Programs at UCLA Health. His professional focus is on diabetes care, research, and improving access to endocrinology services.
Education and Training
Dr. Freeby's medical education and postgraduate training include: * Medical School: Virginia Commonwealth University School of Medicine (Class of 2002). * Residency: Internal Medicine at the University of California, San Diego Medical Center (2002–2005). * Fellowship: Endocrinology, Diabetes, and Metabolism at New York Presbyterian Hospital (Cornell Campus) (2005–2008).
Clinical and Academic Roles
At UCLA, Dr. Freeby sees patients at the Gonda Diabetes Center in Westwood and the UCLA Diabetes Center of Santa Monica. He works closely with a diabetes education team to provide consultations in one-on-one settings and workshops. He leads programs targeting high-risk patients with type 2 diabetes to increase access to endocrinology physicians and organises an annual UCLA Professional Diabetes Symposium for primary care providers and allied health professionals.
Research and Publications
Dr. Freeby has been involved in diabetes-related research, including stem cell research and the evaluation of non-invasive measures of beta cell mass. His publications include: * A study on 11C-Dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and healthy controls, published in the Journal of Nuclear Medicine. * A review on treating obesity in type 1 diabetes mellitus in Current Opinion in Endocrinology, Diabetes, and Obesity. * A study on the efficacy of a video-based education program in improving metabolic surgery perception among patients with obesity and diabetes, published in Surgery for Obesity and Related Diseases. * A qualitative study on the implementation mapping of the Collaborative University of California Teleophthalmology Initiative (CUTI), published in Cureus.
Professional Certifications and Licences
Dr. Freeby is certified by the American Board of Internal Medicine in Endocrinology, Diabetes, and Metabolism. He holds a California State Medical License (2014–2026) and a New York State Medical License (2005–2015). He has also received CMS Meaningful Use Stage 1 and Stage 2 certifications for EpicCare Ambulatory and Allscripts Enterprise EHR.